---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-125433"
form_type: "8-K"
ticker: "CVKD"
cik: "0001937993"
company_name: "Cadrenal Therapeutics, Inc."
filed_at: "2025-12-23T23:59:59+00:00"
generated_at: "2026-05-16T12:19:42.565605+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Cadrenal Therapeutics files prospectus supplement for up to $1.77M ATM offering

## Summary
- Already sold $10,005,300 in shares under the existing ATM agreement since March 2024.
- New tranche of up to $1,770,028 of common stock through H.C. Wainwright as sales agent.
- Commission of 3.0% of gross proceeds payable to Wainwright for its services.
- Offer made under existing effective S-3 registration statement filed March 2024.

## SEC filing metadata
- accession: 0001213900-25-125433
- form_type: 8-K
- ticker: CVKD
- cik: 0001937993
- company_name: Cadrenal Therapeutics, Inc.
- filed_at: 2025-12-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1937993/000121390025125433/0001213900-25-125433-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1937993/000121390025125433/ea0270908-8k_cadrenal.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-125433
- JSON: https://secwatch.observer/filing/0001213900-25-125433.json
- Plain text: https://secwatch.observer/filing/0001213900-25-125433.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.